Terms: = Leukemia AND DCTN1, DAP-150, 1639, ENSG00000204843, Q14203, P135, DP-150 AND Treatment
11 results:
1. PAX5 epigenetically orchestrates CD58 transcription and modulates blinatumomab response in acute lymphoblastic leukemia.
Li Y; Moriyama T; Yoshimura S; Zhao X; Li Z; Yang X; Paietta E; Litzow MR; Konopleva M; Yu J; Inaba H; Ribeiro RC; Pui CH; Yang JJ
Sci Adv; 2022 Dec; 8(50):eadd6403. PubMed ID: 36516256
[TBL] [Abstract] [Full Text] [Related]
2. Identification of Diagnostic Gene Markers and Immune Infiltration in Systemic Lupus.
Hu H; He C
Comput Math Methods Med; 2022; 2022():3386999. PubMed ID: 35558576
[TBL] [Abstract] [Full Text] [Related]
3. Integrated molecular profiling of juvenile myelomonocytic leukemia.
Murakami N; Okuno Y; Yoshida K; Shiraishi Y; Nagae G; Suzuki K; Narita A; Sakaguchi H; Kawashima N; Wang X; Xu Y; Chiba K; Tanaka H; Hama A; Sanada M; Ito M; Hirayama M; Watanabe A; Ueno T; Kojima S; Aburatani H; Mano H; Miyano S; Ogawa S; Takahashi Y; Muramatsu H
Blood; 2018 Apr; 131(14):1576-1586. PubMed ID: 29437595
[TBL] [Abstract] [Full Text] [Related]
4. Elevated Cardiovascular Disease Risk in Patients With Chronic Myelogenous leukemia Seen in Community-based Oncology Practices in the United States.
Coutinho AD; Makenbaeva D; Farrelly E; Landsman-Blumberg PB; Lenihan D
Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):676-683. PubMed ID: 28729178
[TBL] [Abstract] [Full Text] [Related]
5. Philadelphia-Like Acute Lymphoblastic leukemia in Adults.
Herold T; Gökbuget N
Curr Oncol Rep; 2017 May; 19(5):31. PubMed ID: 28361222
[TBL] [Abstract] [Full Text] [Related]
6. Temporal Trends in treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015.
Turcotte LM; Liu Q; Yasui Y; Arnold MA; Hammond S; Howell RM; Smith SA; Weathers RE; Henderson TO; Gibson TM; Leisenring W; Armstrong GT; Robison LL; Neglia JP
JAMA; 2017 Feb; 317(8):814-824. PubMed ID: 28245323
[TBL] [Abstract] [Full Text] [Related]
7. [A Retrospective Study of Ph Negative Adolescent and Young Adults with Acute B Lymphoblastic leukemia in Two Centers].
Gao HH; Jing Y; Liu MJ; Li HH; Huang WR; Gao CJ; Liu DH; Li YH; Huang S; Li Y; Liu J; Zhang YQ; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1683-1690. PubMed ID: 28024477
[TBL] [Abstract] [Full Text] [Related]
8. Risk-Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic leukemia in Adolescents and Young Adults.
Guzauskas GF; Villa KF; Vanhove GF; Fisher VL; Veenstra DL
J Adolesc Young Adult Oncol; 2017 Mar; 6(1):53-61. PubMed ID: 27779442
[TBL] [Abstract] [Full Text] [Related]
9. Malignant hematologic diseases in adolescents and young adults.
Wood WA; Lee SJ
Blood; 2011 Jun; 117(22):5803-15. PubMed ID: 21398581
[TBL] [Abstract] [Full Text] [Related]
10. Favorable response of pediatric stem cell recipients to human protein C concentrate substitution for veno-occlusive disease.
Eber SW; Gungor T; Veldman A; Sykora K; Scherer F; Fischer D; Grigull L
Pediatr Transplant; 2007 Feb; 11(1):49-57. PubMed ID: 17239123
[TBL] [Abstract] [Full Text] [Related]
11. Avascular necrosis of bone after adult acute lymphocytic leukemia treatment with methotrexate, vincristine, L-asparaginase, and dexamethasone (MOAD).
Hui L; Wiernik PH
Am J Hematol; 1996 Jul; 52(3):184-8. PubMed ID: 8756084
[TBL] [Abstract] [Full Text] [Related]
